Patient partners
To do our best for patients, we need to work with them
As the situation with COVID-19 (coronavirus) continues to evolve around the world, hear how we’re responding to the latest developments to ensure continued access to our medicines, diagnostics and clinical trials.
The role of patient groups is continuously evolving, and they are now more equipped than ever to define healthcare in their own terms. Patients are becoming increasingly involved in their treatment and care choices based on their own unique experiences.
Partnering with patients to further understand their everyday lives is essential to evolve the way we look at diseases. It is through collaboration that we can truly personalise healthcare, taking new approaches to develop better medicines for and with the people that matter most - patients
Patients are at the core of what we do. This is why we partner with them at each stage of drug development and care delivery.
Innovation comes from challenging each other for the best possible outcome; I am so excited about all we can achieve together.
The International Experience Exchange with Patient Organisations
The International Experience Exchange with Patient Organisations (IEEPO) is a global platform of engagement for members of the patient community, to co-create and collaborate, and to be strong and impactful partners with an equal voice in the dialogue about shaping future healthcare ecosystems. To find out more information please visit